Dihydroberberine
Dihydroberberine is used in private-label supplement manufacturing. Sourcing, dose anchors and target-market documentation are reviewed per project.
- Type
- Other
- Family
- Functional compounds
- Measured in
- mg
Why brands use Dihydroberberine
Dihydroberberine is a formulation input reviewed per project, sitting in the functional compounds family. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only EU 432/2012- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Dihydroberberine for gummies, powder stick, jelly and strip; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — we don’t publish off-the-shelf doses.
How we use Dihydroberberine in formulas
A public-safe formulation reference — how this active behaves in our formats, common pairings and handling notes. Final formulation, dose and on-pack copy are confirmed per project.
- Heat stable
- Limited — use coated forms
- Soluble in matrix
- Conditional
- Vegan supply
- Project-specific
EU-authorised health claims
EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.
Dihydroberberine is reviewed against the target market’s claim posture: EU 432/2012 wording (UK tracks EU post-Brexit) for the EU/UK route, and DSHEA structure-function wording with the FDA disclosure for the US route. Pack copy is rewritten per market and confirmed per project.
Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.